TICKERNOMICS Sign up
Last Update: 2023-12-23 06:04:15
NEXGEL INC. ( NXGL ) https://nexgel.com
2.13USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
NXGL
56.62%
SPY
30.72%
NXGL
0.00%
SPY
112.82%
NXGL
0.00%
SPY
201.04%
NXGL
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
12.17
11.83
0.01
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-4.73
3.45
1.95
-19.40
0.00
-4.31
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-50.12
28.17
-77.77
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-27.89
-24.32
0.00
Other Earnings and Cash Flow Stats:
NEXGEL INC. ( NXGL ) Net Income TTM ($MM) is -3.30
NEXGEL INC. ( NXGL ) Operating Income TTM ($MM) is -3.31
NEXGEL INC. ( NXGL ) Owners' Earnings Annual ($MM) is 0.00
NEXGEL INC. ( NXGL ) Current Price to Owners' Earnings ratio is 0.00
NEXGEL INC. ( NXGL ) EBITDA TTM ($MM) is -3.03
NEXGEL INC. ( NXGL ) EBITDA Margin is -77.77%
Capital Allocation:
NEXGEL INC. ( NXGL ) has paid 0.00 dividends per share and bought back -0.142082 million shares in the past 12 months
NEXGEL INC. ( NXGL ) has reduced its debt by 2.069 million USD in the last 12 months
Capital Structure:
NEXGEL INC. ( NXGL ) Interest-bearing Debt ($MM) as of last quarter is 0
NEXGEL INC. ( NXGL ) Annual Working Capital Investments ($MM) are 1
NEXGEL INC. ( NXGL ) Book Value ($MM) as of last quarter is 6
NEXGEL INC. ( NXGL ) Debt/Capital as of last quarter is 4%
Other Balance Sheet Stats:
NEXGEL INC. ( NXGL ) has 3 million in cash on hand as of last quarter
NEXGEL INC. ( NXGL ) has 1 million of liabilities due within 12 months, and long term debt 0 as of last quarter
NEXGEL INC. ( NXGL ) has 5 common shares outstanding as of last quarter
NEXGEL INC. ( NXGL ) has 0 million USD of preferred stock value
Academic Scores:
NEXGEL INC. ( NXGL ) Altman Z-Score is -0.08 as of last quarter
NEXGEL INC. ( NXGL ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
NEXGEL INC. ( NXGL ) largest shareholder is Vanguard Group Inc owning 24544 shares at 0.05 ($MM) value
John Nachum Stein(an insider) Bought 2500 shares of NEXGEL INC. ( NXGL ) for the amount of $4900.00 on 2023-09-26
24.17% of NEXGEL INC. ( NXGL ) is held by insiders, and 1.65% is held by institutions
NEXGEL INC. ( NXGL ) went public on 2021-12-22
Other NEXGEL INC. ( NXGL ) financial metrics:
FCF:-2.43
Unlevered Free Cash Flow:0.00
EPS:-0.38
Operating Margin:-50.12
Gross Profit Margin:28.17
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-38.61
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About NEXGEL INC. ( NXGL ) :
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.